project id: TCGA-PAAD; case submitter id: TCGA-3A-A9IR; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.88; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.17; rna integrity number: 8.2; age at index: 64; days to birth: -23406; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1946; age at diagnosis: 23406; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage IB; ajcc pathologic t: T2; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1542.0; icd 10 code: C25.2; last known disease status: not reported; morphology: 8246/3; primary diagnosis: Neuroendocrine carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Tail of pancreas; synchronous malignancy: No; tissue or organ of origin: Tail of pancreas; tumor grade: Not Reported; year of diagnosis: 2010; treatment or therapy: no; alcohol history: Yes; years smoked: 15.0; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 1268; days to sample procurement: 0; initial weight: 50.0; portion submitter id: TCGA-3A-A9IR-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 90.0;